文献速递泌尿男性生殖肿瘤

前列腺癌患者前列腺磁共振成像使用中种族差异的中介因素

Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
PubMed 文献 · JAMA Oncol · 2022-01-01

这项基于美国SEER-Medicare数据库的人群队列研究纳入39 534例局限性前列腺癌患者,采用中介分析评估前列腺磁共振成像(MRI)使用中种族差异的中介因素。黑人患者接受前列腺MRI的比例低于白人患者(6.3% vs 9.9%;未校正OR 0.62,95%CI 0.54-0.70),地理差异、社区贫困、种族化居住隔离和个体社会经济地位标志物分别解释了24%、19%、19%和11%的差异,临床和病理因素不是显著中介因素。

要点

  • 黑人前列腺癌患者接受前列腺MRI的比例低于白人患者(6.3% vs 9.9%)。
  • 地理差异、社区贫困、居住隔离和双重资格分别解释24%、19%、19%和11%的差异。
  • 临床和病理因素不是显著中介因素。

核心结论

  • 中介分析显示,社会经济人口学因素和结构性种族主义的表现(包括贫困和居住隔离)解释了老年黑人和白人前列腺癌患者前列腺MRI使用中大部分的种族差异。

研究设计与样本

  • 基于美国SEER-Medicare数据库的人群队列研究,采用中介分析评估39 534例局限性前列腺癌患者(2011年1月1日至2015年12月31日诊断)的前列腺MRI使用情况。
  • 统计分析时间为2020年4月1日至2021年9月1日。

主要发现

  • 黑人前列腺癌患者接受前列腺MRI的比例低于白人患者(6.3% vs 9.9%;未校正OR 0.62,95%CI 0.54-0.70)。
  • 约24%(95%CI 14%-32%)的前列腺MRI使用种族差异归因于地理差异(SEER登记处)。
  • 19%(95%CI 11%-28%)归因于社区层面社会经济地位(居住于高贫困地区)。
  • 19%(95%CI 10%-29%)归因于种族化居住隔离(ICE五分位)。
  • 11%(95%CI 7%-16%)归因于个体层面社会经济地位标志物(Medicare和Medicaid双重资格)。

关键数值与推荐

  • 临床和病理因素不是显著中介因素。
  • 模型中识别出的中介因素解释了黑人和白人患者之间前列腺MRI使用种族差异的81%(95%CI 64%-98%)。

临床怎么用

  • 这些发现可用于制定针对性策略以改善癌症照护公平性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Racial disparity in the use of prostate magnetic resonance imaging (MRI) presents obstacles to closing gaps in prostate cancer diagnosis, treatment, and outcome. OBJECTIVE: To identify clinical, sociodemographic, and structural processes underlying racial disparity in the use of prostate MRI among men with a new diagnosis of prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study used mediation analysis to assess claims in the US Surveillance, Epidemiology, and End Results (SEER)-Medicare database for prostate MRI among 39 534 patients with a diagnosis of localized prostate cancer from January 1, 2011, to December 31, 2015. Statistical analysis was performed from April 1, 2020, to September 1, 2021. EXPOSURE: Diagnosis of prostate cancer. MAIN OUTCOMES AND MEASURES: Claims for prostate MRI within 6 months before or after diagnosis of prostate cancer were assessed. Candidate clinical and sociodemographic meditators were identified based on their association with both race and prostate MRI, including the Index of Concentration at the Extremes (ICE), as specified to measure racialized residential segregation. Mediation analysis was performed using nonlinear multiple additive regression trees models to estimate the direct and indirect effects of mediators. RESULTS: A total of 39 534 eligible male patients (3979 Black patients [10.1%] and 32 585 White patients [82.4%]; mean [SD] age, 72.8 [5.3] years) were identified. Black patients with prostate cancer were less likely than White patients to receive a prostate MRI (6.3% vs 9.9%; unadjusted odds ratio, 0.62, 95% CI, 0.54-0.70). Approximately 24% (95% CI, 14%-32%) of the racial disparity in prostate MRI use between Black and White patients was attributable to geographic differences (SEER registry), 19% (95% CI, 11%-28%) was attributable to neighborhood-level socioeconomic status (residence in a high-poverty area), 19% (95% CI, 10%-29%) was attributable to racialized residential segregation (ICE quintile), and 11% (95% CI, 7%-16%) was attributable to a marker of individual-level socioeconomic status (dual eligibility for Medicare and Medicaid). Clinical and pathologic factors were not significant mediators. In this model, the identified mediators accounted for 81% (95% CI, 64%-98%) of the observed racial disparity in prostate MRI use between Black and White patients. CONCLUSIONS AND RELEVANCE: In this this population-based cohort study of US adults, mediation analysis revealed that sociodemographic factors and manifestations of structural racism, including poverty and residential segregation, explained most of the racial disparity in the use of prostate MRI among older Black and White men with prostate cancer. These findings can be applied to develop targeted strategies to improve cancer care equity.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Leapman MS, Dinan M, Pasha S, et al. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer. JAMA Oncol. 2022. PMID: 35238879. doi:10.1001/jamaoncol.2021.8116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。